Comparison of major and minor viral SNPs identified through single template sequencing and pyrosequencing in acute HIV-1 infection

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Iyer, Shyamala ^a   Casey, Eleanor ^a   Bouzek, Heather ^a,e   Kim, Moon ^a   Deng, Wenjie ^a   Larsen, Brendan B ^a   Zhao, Hong ^a   Bumgarner, Roger E ^a   Rolland, Morgane ^c,d   Mullins, James I ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Department of Medicine University of Washington ^*  (United States)

^c WRAIR   (United States)

^d Henry Jackson Foundation Advancement of Military Medicine Inc   (United States)

^e Micronics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEF PROTEIN; PLACEBO; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL (TOPIC); FOUNDER EFFECT; GENETIC PROCEDURES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTERMETHOD COMPARISON; NONHUMAN; NUCLEOTIDE SEQUENCE; PHASE 2 CLINICAL TRIAL (TOPIC); PYROSEQUENCING; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE TEMPLATE SEQUENCING; VIRUS GENOME; CHEMISTRY; COMPARATIVE STUDY; DNA SEQUENCE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; PROCEDURES; SENSITIVITY AND SPECIFICITY; VIROLOGY;

DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

EID: 84943311598     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135903     Document Type: Article

References (56)

1. Leitner T, Halapi E, Scarlatti G, Rossi P, Albert J, Fenyo EM, et al. Analysis of heterogeneous viral populations by direct DNA sequencing. BioTechniques. 1993;15(1):120-7. Epub 1993/07/01. PMID: 8363827.
2. Keele BF, Giorgi EE, Salazar-Gonzalez JF, Decker JM, Pham KT, Salazar MG, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A. 2008;105(21):7552-7. Epub 2008/05/21. doi: 0802203105 [pii] doi: 10.1073/pnas. 0802203105 PMID: 18490657; PubMed Central PMCID: PMC2387184.
3. Palmer S, Boltz V, Maldarelli F, Kearney M, Halvas EK, Rock D, et al. Selection and persistence of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy. AIDS. 2006;20(5):701-10. Epub 2006/03/04. doi: 10.1097/01.aids.0000216370.69066.7f 00002030-200603210-00009 [pii]. PMID: 16514300.
4. Wang C, Mitsuya Y, Gharizadeh B, Ronaghi M, Shafer RW. Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res. 2007;17(8):1195-201. PMID: 17600086.
5. Varghese V, Shahriar R, Rhee SY, Liu T, Simen BB, Egholm M, et al. Minority variants associated with transmitted and acquired HIV-1 nonnucleoside reverse transcriptase inhibitor resistance: implications for the use of second-generation nonnucleoside reverse transcriptase inhibitors. J Acquir Immune Defic Syndr. 2009;52(3):309-15. Epub 2009/09/08. doi: 10.1097/QAI.0b013e3181bca669 PMID: 19734799; PubMed Central PMCID: PMC2809083.
6. Li JZ, Paredes R, Ribaudo HJ, Svarovskaia ES, Metzner KJ, Kozal MJ, et al. Low-frequency HIV-1 drug resistance mutations and risk of NNRTI-based antiretroviral treatment failure: a systematic review and pooled analysis. JAMA. 2011;305(13):1327-35. Epub 2011/04/07. doi: 305/13/1327 [pii] doi: 10. 1001/jama.2011.375 PMID: 21467286.
7. Liu J, Miller MD, Danovich RM, Vandergrift N, Cai F, Hicks CB, et al. Analysis of low-frequency mutations associated with drug resistance to raltegravir before antiretroviral treatment. Antimicrob Agents Chemother. 2011;55(3):1114-9. Epub 2010/12/22. doi: AAC.01492-10 [pii] doi: 10.1128/AAC.01492-10 PMID: 21173185; PubMed Central PMCID: PMC3067114.
8. Bimber BN, Burwitz BJ, O'Connor S, Detmer A, Gostick E, Lank SM, et al. Ultradeep pyrosequencing detects complex patterns of CD8+ T-lymphocyte escape in simian immunodeficiency virus-infected macaques. J Virol. 2009;83(16):8247-53. Epub 2009/06/12. doi: 10.1128/jvi.00897-09 PMID: 19515775; PubMed Central PMCID: PMC2715741.
9. Bimber BN, Dudley DM, Lauck M, Becker EA, Chin EN, Lank SM, et al. Whole-genome characterization of human and simian immunodeficiency virus intrahost diversity by ultradeep pyrosequencing. J Virol. 2010;84(22):12087-92. doi: 10.1128/jvi.01378-10 PMID: 20844037; PubMed Central PMCID: PMC2977871.
10. Cooper CJ, Metch B, Dragavon J, Coombs RW, Baden LR, Force NHVTNV-IST. Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients. JAMA: the journal of the American Medical Association. 2010;304(3):275-83. doi: 10.1001/jama.2010.926 PMID: 20639561; PubMed Central PMCID: PMC3086635.
11. Fischer W, Ganusov VV, Giorgi EE, Hraber PT, Keele BF, Leitner T, et al. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One. 2010;5(8):e12303. Epub 2010/09/03. doi: 10.1371/journal.pone.0012303 PMID: 20808830; PubMed Central PMCID: PMC2924888.
12. Love TM, Thurston SW, Keefer MC, Dewhurst S, Lee HY. Mathematical modeling of ultradeep sequencing data reveals that acute CD8+ T-lymphocyte responses exert strong selective pressure in simian immunodeficiency virus-infected macaques but still fail to clear founder epitope sequences. J Virol. 2010;84(11):5802-14. doi: 10.1128/jvi.00117-10 PMID: 20335256; PubMed Central PMCID: PMC2876615.
13. Henn MR, Boutwell CL, Charlebois P, Lennon NJ, Power KA, Macalalad AR, et al. Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog. 2012;8(3):e1002529. Epub 2012/03/14. doi: 10.1371/journal.ppat. 1002529 PMID: 22412369; PubMed Central PMCID: PMC3297584.
14. Schloss PD, Gevers D, Westcott SL. Reducing the effects of PCR amplification and sequencing artifacts on 16S rRNA-based studies. PLoS ONE. 2011;6(12):e27310. Epub 2011/12/24. doi: 10.1371/journal.pone.0027310 PMID: 22194782; PubMed Central PMCID: PMC3237409.
15. Lee CK, Herbold CW, Polson SW, Wommack KE, Williamson SJ, McDonald IR, et al. Groundtruthing next-gen sequencing for microbial ecology-biases and errors in community structure estimates from PCR amplicon pyrosequencing. PLoS ONE. 2012;7(9):e44224. Epub 2012/09/13. doi: 10.1371/journal.pone.0044224 PMID: 22970184; PubMed Central PMCID: PMC3435322.
16. Pinto AJ, Raskin L. PCR biases distort bacterial and archaeal community structure in pyrosequencing datasets. PLoS ONE. 2012;7(8):e43093. Epub 2012/08/21. doi: 10.1371/journal.pone.0043093 PMID: 22905208; PubMed Central PMCID: PMC3419673.
17. Brodin J, Mild M, Hedskog C, Sherwood E, Leitner T, Andersson B, et al. PCR-induced transitions are the major source of error in cleaned ultra-deep pyrosequencing data. PLoS ONE. 2013;8(7):e70388. Epub 2013/07/31. doi: 10.1371/journal.pone.0070388 PMID: 23894647; PubMed Central PMCID: PMC3720931.
18. Shao W, Boltz VF, Spindler JE, Kearney MF, Maldarelli F, Mellors JW, et al. Analysis of 454 sequencing error rate, error sources, and artifact recombination for detection of Low-frequency drug resistance mutations in HIV-1 DNA. Retrovirology. 2013;10:18. doi: 10.1186/1742-4690-10-18 PMID: 23402264; PubMed Central PMCID: PMC3599717.
19. Iyer S, Bouzek H, Deng W, Larsen B, Casey E, Mullins JI. Quality score based identification and correction of pyrosequencing errors. PLoS One. 2013;8(9):e73015. Epub 2013/09/17. doi: 10.1371/journal. pone.0073015 PMID: 24039850; PubMed Central PMCID: PMC3764156.
20. Larsen BB, Chen L, Maust BS, Kim M, Zhao H, Deng W, et al. Improved detection of rare HIV-1 variants using 454 pyrosequencing. PLoS One. 2013;8(10):e76502. Epub 2013/10/08. doi: 10.1371/journal. pone.0076502 PMID: 24098517; PubMed Central PMCID: PMC3788733.
21. Liu S-L, Rodrigo AG, Shankarappa R, Learn GH, Hsu L, Davidov O, et al. HIV quasispecies and resampling. Science. 1996;273(5274):415-6. PMID: 8677432
22. Rodrigo AG, Goracke PC, Rowhanian K, Mullins JI. Quantitation of target molecules from polymerase chain reaction-based limiting dilution assays. AIDS Res and Hum Retrovir. 1997;13(9):737-42.
23. Mallona I, Weiss J, Egea-Cortines M. pcrEfficiency: a Web tool for PCR amplification efficiency prediction. BMC Bioinformatics. 2011;12:404. doi: 10.1186/1471-2105-12-404 PMID: 22014212; PubMed Central PMCID: PMC3234296.
24. Hedskog C, Mild M, Jernberg J, Sherwood E, Bratt G, Leitner T, et al. Dynamics of HIV-1 quasispecies during antiviral treatment dissected using ultra-deep pyrosequencing. PLoS One. 2010;5(7):e11345. doi: 10.1371/journal.pone.0011345 PMID: 20628644; PubMed Central PMCID: PMC2898805.
25. Knierim E, Lucke B, Schwarz JM, Schuelke M, Seelow D. Systematic comparison of three methods for fragmentation of long-range PCR products for next generation sequencing. PLoS ONE. 2011;6(11):e28240. Epub 2011/12/06. doi: 10.1371/journal.pone.0028240 PMID: 22140562; PubMed Central PMCID: PMC3227650.
26. Gilles A, Meglecz E, Pech N, Ferreira S, Malausa T, Martin JF. Accuracy and quality assessment of 454 GS-FLX Titanium pyrosequencing. BMC genomics. 2011;12:245. doi: 10.1186/1471-2164-12-245 PMID: 21592414; PubMed Central PMCID: PMC3116506.
27. Li Y, Chen W, Liu EY, Zhou YH. Single Nucleotide Polymorphism (SNP) Detection and Genotype Calling from Massively Parallel Sequencing (MPS) Data. Statistics in biosciences. 2013;5(1):3-25. Epub 2014/02/04. doi: 10.1007/s12561-012-9067-4 PMID: 24489615; PubMed Central PMCID: PMC3905464.
28. Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol. 2008;26(10):1135-45. Epub 2008/10/11. doi: nbt1486 [pii] doi: 10.1038/nbt1486 PMID: 18846087.
29. Bakker MG, Tu ZJ, Bradeen JM, Kinkel LL. Implications of pyrosequencing error correction for biological data interpretation. PLoS ONE. 2012;7(8):e44357. Epub 2012/09/07. doi: 10.1371/journal.pone. 0044357 PMID: 22952965; PubMed Central PMCID: PMC3431371.
30. Becker EA, Burns CM, Leon EJ, Rajabojan S, Friedman R, Friedrich TC, et al. Experimental analysis of sources of error in evolutionary studies based on Roche/454 pyrosequencing of viral genomes. Genome biology and evolution. 2012;4(4):457-65. Epub 2012/03/23. doi: 10.1093/gbe/evs029 PMID: 22436995; PubMed Central PMCID: PMC3342875.
31. Gianella S, Delport W, Pacold ME, Young JA, Choi JY, Little SJ, et al. Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants. J Virol. 2011;85(16):8359-67. Epub 2011/06/03. doi: 10.1128/JVI. 02582-10 PMID: 21632754; PubMed Central PMCID: PMC3147985.
32. Varghese V, Wang E, Babrzadeh F, Bachmann MH, Shahriar R, Liu T, et al. Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation. PLoS ONE. 2010;5(6):e10992. Epub 2010/06/12. doi: 10.1371/journal.pone.0010992 PMID: 20539818; PubMed Central PMCID: PMC2881873.
33. Quince C, Lanzen A, Curtis TP, Davenport RJ, Hall N, Head IM, et al. Accurate determination of microbial diversity from 454 pyrosequencing data. Nat Methods. 2009;6(9):639-41. Epub 2009/08/12. doi: 10.1038/nmeth.1361 PMID: 19668203.
34. Archer J, Rambaut A, Taillon BE, Harrigan PR, Lewis M, Robertson DL. The evolutionary analysis of emerging low frequency HIV-1 CXCR4 using variants through time-an ultra-deep approach. PLoS Comput Biol. 2010;6(12):e1001022. Epub 2010/12/29. doi: 10.1371/journal.pcbi.1001022 PMID: 21187908; PubMed Central PMCID: PMC3002995.
35. Beerenwinkel N, Zagordi O. Ultra-deep sequencing for the analysis of viral populations. Current opinion in virology. 2011;1(5):413-8. Epub 2012/03/24. doi: 10.1016/j.coviro.2011.07.008 PMID: 22440844.
36. Prosperi MC, Prosperi L, Bruselles A, Abbate I, Rozera G, Vincenti D, et al. Combinatorial analysis and algorithms for quasispecies reconstruction using next-generation sequencing. BMC Bioinformatics. 2011;12:5. Epub 2011/01/07. doi: 10.1186/1471-2105-12-5 PMID: 21208435; PubMed Central PMCID: PMC3022557.
37. Quince C, Lanzen A, Davenport RJ, Turnbaugh PJ. Removing noise from pyrosequenced amplicons. BMC Bioinformatics. 2011;12:38. Epub 2011/02/01. doi: 10.1186/1471-2105-12-38 PMID: 21276213; PubMed Central PMCID: PMC3045300.
38. Salmela L, Schröder J. Correcting errors in short reads by multiple alignments. Bioinformatics. 2011;27(11):1455-61. Epub 2011/04/08. doi: 10.1093/bioinformatics/btr170 PMID: 21471014.
39. Zagordi O, Bhattacharya A, Eriksson N, Beerenwinkel N. ShoRAH: estimating the genetic diversity of a mixed sample from next-generation sequencing data. BMC Bioinformatics. 2011;12:119. Epub 2011/04/28. doi: 10.1186/1471-2105-12-119 PMID: 21521499; PubMed Central PMCID: PMC3113935.
40. Macalalad AR, Zody MC, Charlebois P, Lennon NJ, Newman RM, Malboeuf CM, et al. Highly Sensitive and Specific Detection of Rare Variants in Mixed Viral Populations from Massively Parallel Sequence Data. PLoS Comput Biol. 2012;8(3):e1002417. doi: 10.1371/journal.pcbi.1002417 PMID: 22438797
41. Prosperi MC, Salemi M. QuRe: software for viral quasispecies reconstruction from next-generation sequencing data. Bioinformatics. 2012;28(1):132-3. Epub 2011/11/18. doi: 10.1093/bioinformatics/btr627 PMID: 22088846; PubMed Central PMCID: PMC3244773.
42. Deng W, Maust BS, Westfall DH, Chen L, Zhao H, Larsen BB, et al. Indel and Carryforward Correction (ICC): a new analysis approach for processing 454 pyrosequencing data. Bioinformatics. 2013;29(19):2402-9. Epub 2013/08/01. doi: 10.1093/bioinformatics/btt434 PMID: 23900188; PubMed Central PMCID: PMC3777116.
43. Ji H, Masse N, Tyler S, Liang B, Li Y, Merks H, et al. HIV drug resistance surveillance using pooled pyrosequencing. PLoS ONE. 2010;5(2):e9263. Epub 2010/02/23. doi: 10.1371/journal.pone.0009263 PMID: 20174661; PubMed Central PMCID: PMC2822863.
44. De Wolf H, Van Marck H, Mostmans W, Thys K, Vandenbroucke I, Van Eygen V, et al. HIV-1 nucleotide mixture detection in the virco ((R)) TYPE HIV-1 genotyping assay: a comparison between Sanger sequencing and 454 pyrosequencing. J Virol Methods. 2011;175(1):129-32. Epub 2011/05/10. doi: 10.1016/j.jviromet.2011.04.023 PMID: 21549149.
45. Stelzl E, Proll J, Bizon B, Niklas N, Danzer M, Hackl C, et al. Human immunodeficiency virus type 1 drug resistance testing: Evaluation of a new ultra-deep sequencing-based protocol and comparison with the TRUGENE HIV-1 Genotyping Kit. J Virol Methods. 2011;178(1-2):94-7. Epub 2011/09/13. doi: 10.1016/j.jviromet.2011.08.020 PMID: 21907239.
46. Recordon-Pinson P, Papuchon J, Reigadas S, Deshpande A, Fleury H. K65R in subtype C HIV-1 isolates from patients failing on a first-line regimen including d4T or AZT: comparison of Sanger and UDP sequencing data. PLoS ONE. 2012;7(5):e36549. Epub 2012/05/23. doi: 10.1371/journal.pone. 0036549 PMID: 22615779; PubMed Central PMCID: PMC3353948.
47. Simen BB, Braverman MS, Abbate I, Aerssens J, Bidet Y, Bouchez O, et al. An international multicenter study on HIV-1 drug resistance testing by 454 ultra-deep pyrosequencing. J Virol Methods. 2014;204:31-7. Epub 2014/04/16. doi: 10.1016/j.jviromet.2014.04.007 PMID: 24731928.
48. Liang B, Luo M, Scott-Herridge J, Semeniuk C, Mendoza M, Capina R, et al. A comparison of parallel pyrosequencing and sanger clone-based sequencing and its impact on the characterization of the genetic diversity of HIV-1. PLoS ONE. 2011;6(10):e26745. Epub 2011/11/01. doi: 10.1371/journal. pone.0026745 PMID: 22039546; PubMed Central PMCID: PMC3198814.
49. Jabara CB, Jones CD, Roach J, Anderson JA, Swanstrom R. Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID. Proc Natl Acad Sci U S A. 2011;108(50):20166-71. Epub 2011/12/03. doi: 1110064108 [pii] doi: 10.1073/pnas.1110064108 PMID: 22135472; PubMed Central PMCID: PMC3250168.
50. Carlson JM, Schaefer M, Monaco DC, Batorsky R, Claiborne DT, Prince J, et al. HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck. Science. 2014;345(6193):1254031. Epub 2014/07/12. doi: 10.1126/science.1254031 PMID: 25013080.
51. Rolland M, Tovanabutra S, De Camp AC, Frahm N, Gilbert PB, Sanders-Buell E, et al. Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nature medicine. 2011;17(3):366-71. Epub 2011/03/02. doi: 10.1038/nm.2316 PMID: 21358627; PubMed Central PMCID: PMC3053571.
52. Buchbinder SP, Mehrotra DV, Duerr A, Fitzgerald DW, Mogg R, Li D, et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet. 2008;372(9653):1881-93. Epub 2008/11/18. doi: S0140-6736 (08) 61591-3 [pii] doi: 10.1016/S0140-6736 (08) 61591-3 PMID: 19012954.
53. McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, Janes H, et al. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet. 2008;372(9653):1894-905. PMID: 19012957. doi: 10.1016/S0140-6736 (08) 61592-5
54. Deng W, Maust BS, Nickle DC, Learn GH, Liu Y, Heath L, et al. DIVEIN: A Web Server to Analyze Phylogenies, Sequence Divergence, Diversity, and Informative Sites. Biotechniques. 2010;48(5):405-8. PubMed Central PMCID: PMC3133969. doi: 10.2144/000113370 PMID: 20569214
55. Gonzalez JM, Portillo MC, Belda-Ferre P, Mira A. Amplification by PCR artificially reduces the proportion of the rare biosphere in microbial communities. PLoS ONE. 2012;7(1):e29973. Epub 2012/01/19. doi: 10.1371/journal.pone.0029973 PMID: 22253843; PubMed Central PMCID: PMC3256211.
56. Kennedy SR, Schmitt MW, Fox EJ, Kohrn BF, Salk JJ, Ahn EH, et al. Detecting ultralow-frequency mutations by Duplex Sequencing. Nat Protoc. 2014;9(11):2586-606. doi: 10.1038/nprot.2014.170 PMID: 25299156.